Bio-Rad LaboratoriesBIO
紐約證券 · USD
284.60
+42.65
(+17.63%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Bio-Rad LaboratoriesBIO
284.60
+42.65
(+17.63%)
財務數據
損益表
- 7.30
- 6.77
- 6.81
- 6.32
- 6.81
- 6.11
- 6.38
- 6.50
- 6.67
- 5.85
- 7.27
- -7.32
- 0.63
- -7.19
- 7.76
- -10.33
- 4.53
- 1.76
- 2.73
- -12.30
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 585,400 | 667,475 | 649,729 | 638,496 | 610,820 | 681,184 | 632,124 | 681,110 | 676,844 | 730,288 |
營業成本 | 279,400 | 325,563 | 293,826 | 283,311 | 284,854 | 314,821 | 296,441 | 318,627 | 314,427 | 333,191 |
營業毛利 | 306,000 | 341,912 | 355,903 | 355,185 | 325,966 | 366,363 | 335,683 | 362,483 | 362,417 | 397,097 |
營業費用 | - | - | 291,437 | - | - | 271,046 | 244,734 | 272,866 | 300,504 | 278,427 |
研發費用 | 73,500 | 79,624 | 90,997 | 58,879 | 66,375 | 63,899 | 43,535 | 65,042 | 74,951 | 66,200 |
推銷及管理費用 | 208,800 | 203,958 | 200,440 | 194,702 | 214,883 | 207,147 | 201,199 | 207,824 | 225,553 | 212,227 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 23,700 | 58,330 | 64,466 | 101,604 | 44,708 | 95,317 | 90,949 | 89,617 | 61,913 | 118,670 |
其他收入及費用 | 71,700 | -955,062 | 809,328 | -2,875,666 | 458,647 | 345,436 | 58,551 | -1,577,701 | 35,253 | 984,295 |
利息費用 | 12,000 | 12,185 | 12,174 | 12,241 | 12,277 | 12,361 | 12,398 | 12,343 | 12,337 | 11,683 |
稅前純益 | 83,400 | -908,917 | 861,620 | -2,786,303 | 491,078 | 428,392 | 137,102 | -1,500,427 | 84,829 | 1,091,282 |
所得稅 | 19,400 | -193,115 | 208,448 | -620,833 | 107,162 | 78,684 | 30,845 | -338,176 | 15,867 | 263,548 |
稅後純益 | 64,000 | -715,802 | 653,172 | -2,165,470 | 383,916 | 349,708 | 106,257 | -1,162,251 | 68,962 | 827,734 |
基本每股稅後盈餘(元) | 2.29 | -25.57 | 23.37 | -76.26 | 13.46 | - | 3.65 | -39.59 | 2.33 | 27.89 |
稀釋每股稅後盈餘(元) | 2.29 | -25.47 | 22.72 | -76.06 | 13.45 | 11.81 | 3.46 | -39.41 | 2.32 | 27.62 |
基本平均股數(千股) | 27941.00 | 27997.00 | 27949.00 | 28395.00 | 28518.00 | - | 29102.00 | 29355.00 | 29596.00 | 29683.00 |
稀釋平均股數(千股) | 27955.00 | 27997.00 | 27985.00 | 28395.00 | 28537.00 | - | 29223.00 | 29355.00 | 29747.00 | 29792.00 |
還原基本每股稅後盈餘(元) | 2.29 | -25.57 | 23.37 | -76.26 | 13.46 | - | 3.65 | -39.59 | 2.33 | 27.89 |
還原稀釋每股稅後盈餘(元) | 2.29 | -25.47 | 22.72 | -76.06 | 13.45 | 11.81 | 3.46 | -39.41 | 2.32 | 27.62 |
還原基本平均股數(千股) | 27,941 | 27,997 | 27,949 | 28,395 | 28,518 | - | 29,102 | 29,355 | 29,596 | 29,683 |
還原稀釋平均股數(千股) | 27,955 | 27,997 | 27,985 | 28,395 | 28,537 | - | 29,223 | 29,355 | 29,747 | 29,792 |
EBITDA(千元) | 95,400 | -896,732 | 873,794 | -2,774,062 | 503,355 | 440,753 | 149,500 | -1,488,084 | 97,166 | 1,102,965 |